See this page online at: http://www.laboratoryfocus.com/2007Issue1
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
A Practical Guide To Post-Marketing Observational Studies (PMOS) By John S. Sampalis, PhD What to do and what to avoid
In the spectrum of designs available for the evaluation of medical and, specifically, pharmaceutical interventions, the Post-Marketing Phase IV or Observational Study has been considered as the black sheep of the family. |
|
National Investment Key Factor In Successful R&D Regions Worldwide And Canada By Ross McGregor "We know that the countries and jurisdictions that invest in innovation, that tap the creativity of their
people, that market their ideas most effectively, will be home to the most rewarding jobs, the strongest economies and the best quality of life." Ontario Premier Dalton McGuinty, Minister of Research and Innovation (October 7, 2005). |
|
STEM CELLS--science, ethics and politics at the forefront of biomedical innovation By Shane K. Green, PhD In the early 1960s, two researchers at the Ontario Cancer Institute in Toronto performed a series of experiments that led to a remarkable discovery - and the 2005 Lasker Award for Basic Medical Research.
|
|
Getting To The Point Of Success Through Passion And Patience By Tonya Costoff Passion and patience is what got Dr. T. Nathan Yoganathan where he is today. And just where that is, is the president and chief scientific officer of Med BioGene (MBI), a biotechnology company that is revolutionizing the diagnosis and treatment of certain cancers and cardiovascular disease by identifying the genes known as 'biomarkers', that indicate the presence of such diseases.
|